The minimum duration of pulselessness required before organ donation after circulatory determination of death has not been well studied. We conducted a prospective observational study of the incidence ...
MARLBOROUGH, Mass., April 16, 2025--(BUSINESS WIRE)--CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, announced the continuation of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback